Scholtz & Company’s Diebold Nixdorf Incorporated DBD Stock Holding History
Bought
Maintained
Sold
Other funds holding DBD
GI
SAM
RA
DCM
BFA
Scholtz & Company's DBD Position: Q3 2014 in Review
Scholtz & Company sold out of Diebold Nixdorf Incorporated (DBD) in Q3 2014, closing a stake of 6,000 shares — an estimated $241K sold.
Scholtz & Company first reported a position in DBD in Q1 2014 and held it in 2 quarters. The position peaked at $241K in Q2 2014. 254 funds tracked by Wall St. Rank hold DBD as of Q3 2014.
- Scholtz & Company reported no remaining Diebold Nixdorf Incorporated position as of Q3 2014 after selling out during the quarter.
- Scholtz & Company sold 6,000 Diebold Nixdorf Incorporated shares in Q3 2014, an estimated $241K.
- Scholtz & Company first reported a position in Diebold Nixdorf Incorporated in Q1 2014 and held it in 2 quarters.
- Scholtz & Company's Diebold Nixdorf Incorporated position peaked at $241K in Q2 2014.
- 254 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q3 2014.
Based on Scholtz & Company's 13F filing for Q3 2014, filed 13 Nov 2014.